nodes	percent_of_prediction	percent_of_DWPC	metapath
Daunorubicin—Topoisomerase Inhibitors—Etoposide—germ cell cancer	0.529	1	CiPCiCtD
Daunorubicin—NR5A1—Vinblastine—germ cell cancer	0.0564	0.162	CbGbCtD
Daunorubicin—TOP2B—Etoposide—germ cell cancer	0.0508	0.146	CbGbCtD
Daunorubicin—ABCC6—Dactinomycin—germ cell cancer	0.0343	0.0988	CbGbCtD
Daunorubicin—ABCC6—Vinblastine—germ cell cancer	0.0215	0.0619	CbGbCtD
Daunorubicin—ABCC6—Cisplatin—germ cell cancer	0.0197	0.0567	CbGbCtD
Daunorubicin—ABCC6—Etoposide—germ cell cancer	0.0194	0.0558	CbGbCtD
Daunorubicin—ABCC10—Etoposide—germ cell cancer	0.0148	0.0426	CbGbCtD
Daunorubicin—XDH—Cisplatin—germ cell cancer	0.0123	0.0355	CbGbCtD
Daunorubicin—TOP2A—Etoposide—germ cell cancer	0.0103	0.0297	CbGbCtD
Daunorubicin—ABCC1—Dactinomycin—germ cell cancer	0.0101	0.0291	CbGbCtD
Daunorubicin—ABCC10—Methotrexate—germ cell cancer	0.00978	0.0281	CbGbCtD
Daunorubicin—ABCB11—Vinblastine—germ cell cancer	0.00893	0.0257	CbGbCtD
Daunorubicin—ABCG2—Dactinomycin—germ cell cancer	0.00678	0.0195	CbGbCtD
Daunorubicin—ABCC1—Vinblastine—germ cell cancer	0.00635	0.0183	CbGbCtD
Daunorubicin—SLC22A2—Vinblastine—germ cell cancer	0.00575	0.0165	CbGbCtD
Daunorubicin—ABCC1—Etoposide—germ cell cancer	0.00572	0.0164	CbGbCtD
Daunorubicin—SLC22A2—Cisplatin—germ cell cancer	0.00527	0.0152	CbGbCtD
Daunorubicin—ABCC2—Vinblastine—germ cell cancer	0.0047	0.0135	CbGbCtD
Daunorubicin—CYP3A5—Ifosfamide—germ cell cancer	0.00443	0.0128	CbGbCtD
Daunorubicin—ABCC2—Cisplatin—germ cell cancer	0.00431	0.0124	CbGbCtD
Daunorubicin—ABCC2—Etoposide—germ cell cancer	0.00423	0.0122	CbGbCtD
Daunorubicin—NR5A1—seminiferous tubule of testis—germ cell cancer	0.00404	0.132	CbGeAlD
Daunorubicin—ABCG2—Cisplatin—germ cell cancer	0.00389	0.0112	CbGbCtD
Daunorubicin—ABCG2—Etoposide—germ cell cancer	0.00383	0.011	CbGbCtD
Daunorubicin—ABCC1—Methotrexate—germ cell cancer	0.00378	0.0109	CbGbCtD
Daunorubicin—NR5A1—Transcriptional regulation of pluripotent stem cells—TDGF1—germ cell cancer	0.0028	0.0873	CbGpPWpGaD
Daunorubicin—ABCC2—Methotrexate—germ cell cancer	0.0028	0.00804	CbGbCtD
Daunorubicin—ABCG2—Methotrexate—germ cell cancer	0.00253	0.00727	CbGbCtD
Daunorubicin—ABCB1—Dactinomycin—germ cell cancer	0.00244	0.00703	CbGbCtD
Daunorubicin—NR5A1—Transcriptional regulation of pluripotent stem cells—SALL4—germ cell cancer	0.00238	0.0743	CbGpPWpGaD
Daunorubicin—NR5A1—Transcriptional regulation of pluripotent stem cells—NANOG—germ cell cancer	0.00228	0.0712	CbGpPWpGaD
Daunorubicin—NR5A1—Transcriptional regulation of pluripotent stem cells—POU5F1—germ cell cancer	0.00219	0.0685	CbGpPWpGaD
Daunorubicin—CYP3A5—Etoposide—germ cell cancer	0.00212	0.0061	CbGbCtD
Daunorubicin—ABCC6—dermis—germ cell cancer	0.00211	0.0686	CbGeAlD
Daunorubicin—CYP3A4—Ifosfamide—germ cell cancer	0.00173	0.00497	CbGbCtD
Daunorubicin—NR5A1—Transcriptional regulation of pluripotent stem cells—KLF4—germ cell cancer	0.00173	0.054	CbGpPWpGaD
Daunorubicin—NR5A1—Nuclear Receptors—NR0B1—germ cell cancer	0.00164	0.0511	CbGpPWpGaD
Daunorubicin—CYP1A2—Etoposide—germ cell cancer	0.00158	0.00454	CbGbCtD
Daunorubicin—ABCB1—Vinblastine—germ cell cancer	0.00153	0.0044	CbGbCtD
Daunorubicin—ABCB1—Cisplatin—germ cell cancer	0.0014	0.00404	CbGbCtD
Daunorubicin—NR5A1—Ovarian Infertility Genes—INHA—germ cell cancer	0.00138	0.0432	CbGpPWpGaD
Daunorubicin—ABCB1—Etoposide—germ cell cancer	0.00138	0.00397	CbGbCtD
Daunorubicin—NR5A1—Nuclear Receptor transcription pathway—NR0B1—germ cell cancer	0.00129	0.0404	CbGpPWpGaD
Daunorubicin—NR5A1—Transcriptional regulation of pluripotent stem cells—SOX2—germ cell cancer	0.00122	0.038	CbGpPWpGaD
Daunorubicin—ABCG2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00115	0.0359	CbGpPWpGaD
Daunorubicin—SLC22A2—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.00114	0.0355	CbGpPWpGaD
Daunorubicin—CYP3A4—Vinblastine—germ cell cancer	0.000917	0.00264	CbGbCtD
Daunorubicin—ABCB1—Methotrexate—germ cell cancer	0.000911	0.00262	CbGbCtD
Daunorubicin—CYP3A4—Etoposide—germ cell cancer	0.000826	0.00238	CbGbCtD
Daunorubicin—SLC22A2—Organic cation transport—SLC22A3—germ cell cancer	0.000781	0.0244	CbGpPWpGaD
Daunorubicin—ABCG2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.00066	0.0206	CbGpPWpGaD
Daunorubicin—SLC22A2—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000653	0.0204	CbGpPWpGaD
Daunorubicin—ABCB1—Abacavir transmembrane transport—SLC22A3—germ cell cancer	0.000621	0.0194	CbGpPWpGaD
Daunorubicin—TOP2B—Teniposide—Etoposide—germ cell cancer	0.000558	0.361	CbGdCrCtD
Daunorubicin—SLC22A2—Organic cation/anion/zwitterion transport—SLC22A3—germ cell cancer	0.00053	0.0165	CbGpPWpGaD
Daunorubicin—ABCC6—Podofilox—Etoposide—germ cell cancer	0.000498	0.322	CbGdCrCtD
Daunorubicin—NR5A1—brainstem—germ cell cancer	0.000463	0.015	CbGeAlD
Daunorubicin—YWHAG—a6b1 and a6b4 Integrin signaling—CD9—germ cell cancer	0.000459	0.0143	CbGpPWpGaD
Daunorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—SALL4—germ cell cancer	0.000456	0.0142	CbGpPWpGaD
Daunorubicin—ABCB1—Abacavir transport and metabolism—SLC22A3—germ cell cancer	0.000357	0.0111	CbGpPWpGaD
Daunorubicin—ABCG2—HIF-2-alpha transcription factor network—POU5F1—germ cell cancer	0.000355	0.0111	CbGpPWpGaD
Daunorubicin—CYP1A2—urine—germ cell cancer	0.000351	0.0114	CbGeAlD
Daunorubicin—YWHAG—trigeminal ganglion—germ cell cancer	0.000345	0.0112	CbGeAlD
Daunorubicin—NR5A1—gonad—germ cell cancer	0.000343	0.0111	CbGeAlD
Daunorubicin—NR5A1—pituitary gland—germ cell cancer	0.000334	0.0109	CbGeAlD
Daunorubicin—TOP2B—trigeminal ganglion—germ cell cancer	0.000333	0.0108	CbGeAlD
Daunorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—KLF4—germ cell cancer	0.000331	0.0103	CbGpPWpGaD
Daunorubicin—TOP2B—embryo—germ cell cancer	0.000321	0.0105	CbGeAlD
Daunorubicin—ABCC6—eye—germ cell cancer	0.000316	0.0103	CbGeAlD
Daunorubicin—ABCC6—retina—germ cell cancer	0.000313	0.0102	CbGeAlD
Daunorubicin—NR5A1—adrenal gland—germ cell cancer	0.000299	0.00971	CbGeAlD
Daunorubicin—YWHAG—eye—germ cell cancer	0.000297	0.00968	CbGeAlD
Daunorubicin—YWHAG—retina—germ cell cancer	0.000295	0.00959	CbGeAlD
Daunorubicin—TOP2B—brainstem—germ cell cancer	0.000294	0.00958	CbGeAlD
Daunorubicin—TOP2B—eye—germ cell cancer	0.000287	0.00933	CbGeAlD
Daunorubicin—TOP2B—retina—germ cell cancer	0.000284	0.00924	CbGeAlD
Daunorubicin—CYP1A1—skin epidermis—germ cell cancer	0.00028	0.00911	CbGeAlD
Daunorubicin—NR5A1—female gonad—germ cell cancer	0.000278	0.00906	CbGeAlD
Daunorubicin—CYP1B1—Metapathway biotransformation—NAT9—germ cell cancer	0.000275	0.00858	CbGpPWpGaD
Daunorubicin—YWHAG—telencephalon—germ cell cancer	0.000271	0.00882	CbGeAlD
Daunorubicin—SLC22A2—trigeminal ganglion—germ cell cancer	0.000264	0.00859	CbGeAlD
Daunorubicin—POR—trigeminal ganglion—germ cell cancer	0.000263	0.00854	CbGeAlD
Daunorubicin—TOP2B—telencephalon—germ cell cancer	0.000261	0.0085	CbGeAlD
Daunorubicin—NR5A1—endocrine gland—germ cell cancer	0.000259	0.00842	CbGeAlD
Daunorubicin—YWHAG—decidua—germ cell cancer	0.000257	0.00836	CbGeAlD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.000256	0.008	CbGpPWpGaD
Daunorubicin—NR5A1—head—germ cell cancer	0.000256	0.00831	CbGeAlD
Daunorubicin—CYP3A4—urine—germ cell cancer	0.000254	0.00826	CbGeAlD
Daunorubicin—TOP2B—decidua—germ cell cancer	0.000248	0.00806	CbGeAlD
Daunorubicin—NR5A1—testis—germ cell cancer	0.000247	0.00803	CbGeAlD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.000246	0.0077	CbGpPWpGaD
Daunorubicin—NR5A1—cerebellum—germ cell cancer	0.000228	0.00742	CbGeAlD
Daunorubicin—YWHAG—gonad—germ cell cancer	0.000226	0.00736	CbGeAlD
Daunorubicin—YWHAG—uterus—germ cell cancer	0.000225	0.00732	CbGeAlD
Daunorubicin—NR5A1—Developmental Biology—TDGF1—germ cell cancer	0.000224	0.00698	CbGpPWpGaD
Daunorubicin—NR5A1—Generic Transcription Pathway—NR0B1—germ cell cancer	0.000223	0.00697	CbGpPWpGaD
Daunorubicin—YWHAG—pituitary gland—germ cell cancer	0.000221	0.00718	CbGeAlD
Daunorubicin—TOP2B—gonad—germ cell cancer	0.000218	0.0071	CbGeAlD
Daunorubicin—TOP2B—uterus—germ cell cancer	0.000217	0.00705	CbGeAlD
Daunorubicin—YWHAG—medulla oblongata—germ cell cancer	0.000213	0.00693	CbGeAlD
Daunorubicin—TOP2B—pituitary gland—germ cell cancer	0.000213	0.00692	CbGeAlD
Daunorubicin—ABCC10—trigeminal ganglion—germ cell cancer	0.000208	0.00678	CbGeAlD
Daunorubicin—TOP2B—medulla oblongata—germ cell cancer	0.000205	0.00668	CbGeAlD
Daunorubicin—YWHAG—adrenal gland—germ cell cancer	0.000197	0.00642	CbGeAlD
Daunorubicin—POR—decidua—germ cell cancer	0.000195	0.00636	CbGeAlD
Daunorubicin—YWHAG—midbrain—germ cell cancer	0.000195	0.00634	CbGeAlD
Daunorubicin—YWHAG—bone marrow—germ cell cancer	0.000191	0.00621	CbGeAlD
Daunorubicin—TOP2B—adrenal gland—germ cell cancer	0.00019	0.00618	CbGeAlD
Daunorubicin—NR5A1—Developmental Biology—SALL4—germ cell cancer	0.00019	0.00594	CbGpPWpGaD
Daunorubicin—YWHAG—spinal cord—germ cell cancer	0.00019	0.00618	CbGeAlD
Daunorubicin—TOP2B—midbrain—germ cell cancer	0.000188	0.00611	CbGeAlD
Daunorubicin—NR5A1—brain—germ cell cancer	0.000185	0.00603	CbGeAlD
Daunorubicin—YWHAG—female gonad—germ cell cancer	0.000184	0.00598	CbGeAlD
Daunorubicin—TOP2B—bone marrow—germ cell cancer	0.000184	0.00598	CbGeAlD
Daunorubicin—TOP2B—spinal cord—germ cell cancer	0.000183	0.00596	CbGeAlD
Daunorubicin—NR5A1—Developmental Biology—NANOG—germ cell cancer	0.000182	0.00569	CbGpPWpGaD
Daunorubicin—TOP2A—decidua—germ cell cancer	0.000182	0.00593	CbGeAlD
Daunorubicin—ABCC6—endocrine gland—germ cell cancer	0.000182	0.00591	CbGeAlD
Daunorubicin—ABCC6—head—germ cell cancer	0.000179	0.00583	CbGeAlD
Daunorubicin—CYP3A5—Metapathway biotransformation—NAT9—germ cell cancer	0.000179	0.00559	CbGpPWpGaD
Daunorubicin—TOP2B—female gonad—germ cell cancer	0.000177	0.00577	CbGeAlD
Daunorubicin—NR5A1—Developmental Biology—POU5F1—germ cell cancer	0.000175	0.00548	CbGpPWpGaD
Daunorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—FGF4—germ cell cancer	0.000171	0.00535	CbGpPWpGaD
Daunorubicin—YWHAG—endocrine gland—germ cell cancer	0.000171	0.00556	CbGeAlD
Daunorubicin—CYP1A1—Metapathway biotransformation—NAT9—germ cell cancer	0.000169	0.00528	CbGpPWpGaD
Daunorubicin—YWHAG—head—germ cell cancer	0.000169	0.00549	CbGeAlD
Daunorubicin—POR—pituitary gland—germ cell cancer	0.000168	0.00546	CbGeAlD
Daunorubicin—XDH—endocrine gland—germ cell cancer	0.000167	0.00543	CbGeAlD
Daunorubicin—TOP2B—endocrine gland—germ cell cancer	0.000165	0.00536	CbGeAlD
Daunorubicin—ABCC6—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000165	0.00514	CbGpPWpGaD
Daunorubicin—ABCC10—telencephalon—germ cell cancer	0.000164	0.00532	CbGeAlD
Daunorubicin—YWHAG—testis—germ cell cancer	0.000163	0.00531	CbGeAlD
Daunorubicin—ABCB11—endocrine gland—germ cell cancer	0.000163	0.0053	CbGeAlD
Daunorubicin—TOP2B—head—germ cell cancer	0.000163	0.00529	CbGeAlD
Daunorubicin—POR—medulla oblongata—germ cell cancer	0.000162	0.00527	CbGeAlD
Daunorubicin—TOP2A—uterus—germ cell cancer	0.000159	0.00518	CbGeAlD
Daunorubicin—TOP2B—testis—germ cell cancer	0.000157	0.00511	CbGeAlD
Daunorubicin—ABCB11—testis—germ cell cancer	0.000155	0.00506	CbGeAlD
Daunorubicin—ABCC10—decidua—germ cell cancer	0.000155	0.00504	CbGeAlD
Daunorubicin—YWHAG—cerebellum—germ cell cancer	0.000151	0.0049	CbGeAlD
Daunorubicin—POR—adrenal gland—germ cell cancer	0.00015	0.00488	CbGeAlD
Daunorubicin—POR—midbrain—germ cell cancer	0.000148	0.00482	CbGeAlD
Daunorubicin—TOP2B—cerebellum—germ cell cancer	0.000145	0.00472	CbGeAlD
Daunorubicin—POR—bone marrow—germ cell cancer	0.000145	0.00472	CbGeAlD
Daunorubicin—POR—spinal cord—germ cell cancer	0.000144	0.0047	CbGeAlD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000144	0.00449	CbGpPWpGaD
Daunorubicin—TOP2A—Vindesine—Vinblastine—germ cell cancer	0.000143	0.0925	CbGdCrCtD
Daunorubicin—CYP1B1—eye—germ cell cancer	0.000141	0.00459	CbGeAlD
Daunorubicin—POR—female gonad—germ cell cancer	0.00014	0.00455	CbGeAlD
Daunorubicin—TOP2A—adrenal gland—germ cell cancer	0.00014	0.00455	CbGeAlD
Daunorubicin—NR5A1—Developmental Biology—KLF4—germ cell cancer	0.000138	0.00431	CbGpPWpGaD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000137	0.00427	CbGpPWpGaD
Daunorubicin—ABCC10—gonad—germ cell cancer	0.000137	0.00444	CbGeAlD
Daunorubicin—ABCC10—uterus—germ cell cancer	0.000136	0.00441	CbGeAlD
Daunorubicin—TOP2A—bone marrow—germ cell cancer	0.000135	0.0044	CbGeAlD
Daunorubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A3—germ cell cancer	0.000135	0.00421	CbGpPWpGaD
Daunorubicin—ABCC10—pituitary gland—germ cell cancer	0.000133	0.00433	CbGeAlD
Daunorubicin—TOP2A—female gonad—germ cell cancer	0.00013	0.00424	CbGeAlD
Daunorubicin—POR—endocrine gland—germ cell cancer	0.00013	0.00423	CbGeAlD
Daunorubicin—CYP1B1—telencephalon—germ cell cancer	0.000129	0.00419	CbGeAlD
Daunorubicin—ABCC10—medulla oblongata—germ cell cancer	0.000129	0.00418	CbGeAlD
Daunorubicin—POR—testis—germ cell cancer	0.000124	0.00404	CbGeAlD
Daunorubicin—CYP1B1—skin of body—germ cell cancer	0.000123	0.00399	CbGeAlD
Daunorubicin—YWHAG—brain—germ cell cancer	0.000122	0.00398	CbGeAlD
Daunorubicin—ABCG2—trigeminal ganglion—germ cell cancer	0.000122	0.00397	CbGeAlD
Daunorubicin—CYP1B1—decidua—germ cell cancer	0.000122	0.00397	CbGeAlD
Daunorubicin—ABCC10—adrenal gland—germ cell cancer	0.000119	0.00387	CbGeAlD
Daunorubicin—YWHAG—lymph node—germ cell cancer	0.000118	0.00385	CbGeAlD
Daunorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—OXT—germ cell cancer	0.000118	0.00369	CbGpPWpGaD
Daunorubicin—TOP2B—brain—germ cell cancer	0.000118	0.00384	CbGeAlD
Daunorubicin—ABCC10—midbrain—germ cell cancer	0.000117	0.00382	CbGeAlD
Daunorubicin—YWHAG—Cell Cycle—KITLG—germ cell cancer	0.000116	0.00362	CbGpPWpGaD
Daunorubicin—ABCC1—telencephalon—germ cell cancer	0.000116	0.00376	CbGeAlD
Daunorubicin—TOP2A—testis—germ cell cancer	0.000116	0.00376	CbGeAlD
Daunorubicin—ABCC10—bone marrow—germ cell cancer	0.000115	0.00375	CbGeAlD
Daunorubicin—ABCC10—spinal cord—germ cell cancer	0.000115	0.00373	CbGeAlD
Daunorubicin—POR—cerebellum—germ cell cancer	0.000115	0.00373	CbGeAlD
Daunorubicin—TOP2B—lymph node—germ cell cancer	0.000114	0.00371	CbGeAlD
Daunorubicin—ABCC10—female gonad—germ cell cancer	0.000111	0.00361	CbGeAlD
Daunorubicin—YWHAG—Activation of BH3-only proteins—TP53—germ cell cancer	0.00011	0.00344	CbGpPWpGaD
Daunorubicin—ABCC1—decidua—germ cell cancer	0.00011	0.00357	CbGeAlD
Daunorubicin—CYP1A2—Metapathway biotransformation—NAT9—germ cell cancer	0.000108	0.00337	CbGpPWpGaD
Daunorubicin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.000108	0.00336	CbGpPWpGaD
Daunorubicin—ABCC6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000108	0.00336	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—NR0B1—germ cell cancer	0.000108	0.00336	CbGpPWpGaD
Daunorubicin—CYP1B1—gonad—germ cell cancer	0.000107	0.00349	CbGeAlD
Daunorubicin—CYP1B1—uterus—germ cell cancer	0.000107	0.00347	CbGeAlD
Daunorubicin—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.000106	0.00331	CbGpPWpGaD
Daunorubicin—ABCC6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000106	0.00331	CbGpPWpGaD
Daunorubicin—CYP1B1—pituitary gland—germ cell cancer	0.000105	0.00341	CbGeAlD
Daunorubicin—ABCC10—endocrine gland—germ cell cancer	0.000103	0.00336	CbGeAlD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	0.0001	0.00312	CbGpPWpGaD
Daunorubicin—ABCC10—testis—germ cell cancer	9.84e-05	0.0032	CbGeAlD
Daunorubicin—ABCB1—blood vessel—germ cell cancer	9.74e-05	0.00317	CbGeAlD
Daunorubicin—NR5A1—Developmental Biology—SOX2—germ cell cancer	9.73e-05	0.00304	CbGpPWpGaD
Daunorubicin—ABCC1—uterus—germ cell cancer	9.59e-05	0.00312	CbGeAlD
Daunorubicin—ABCG2—telencephalon—germ cell cancer	9.58e-05	0.00312	CbGeAlD
Daunorubicin—ABCC2—adrenal gland—germ cell cancer	9.56e-05	0.00311	CbGeAlD
Daunorubicin—ABCC1—pituitary gland—germ cell cancer	9.42e-05	0.00307	CbGeAlD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	9.41e-05	0.00294	CbGpPWpGaD
Daunorubicin—CYP1B1—adrenal gland—germ cell cancer	9.36e-05	0.00304	CbGeAlD
Daunorubicin—NR5A1—Gene Expression—DNMT3L—germ cell cancer	9.32e-05	0.00291	CbGpPWpGaD
Daunorubicin—POR—brain—germ cell cancer	9.3e-05	0.00303	CbGeAlD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	9.27e-05	0.0029	CbGpPWpGaD
Daunorubicin—ABCC10—cerebellum—germ cell cancer	9.09e-05	0.00296	CbGeAlD
Daunorubicin—ABCG2—decidua—germ cell cancer	9.08e-05	0.00295	CbGeAlD
Daunorubicin—TOP2A—Vinorelbine—Vinblastine—germ cell cancer	9.03e-05	0.0584	CbGdCrCtD
Daunorubicin—ABCC2—NRF2 pathway—SLC2A3—germ cell cancer	9.02e-05	0.00282	CbGpPWpGaD
Daunorubicin—TOP2A—Teniposide—Etoposide—germ cell cancer	9.02e-05	0.0583	CbGdCrCtD
Daunorubicin—TOP2A—Podofilox—Etoposide—germ cell cancer	9.02e-05	0.0583	CbGdCrCtD
Daunorubicin—POR—lymph node—germ cell cancer	8.99e-05	0.00292	CbGeAlD
Daunorubicin—Arrhythmia—Ifosfamide—germ cell cancer	8.75e-05	0.00148	CcSEcCtD
Daunorubicin—CYP1B1—female gonad—germ cell cancer	8.73e-05	0.00284	CbGeAlD
Daunorubicin—Cough—Bleomycin—germ cell cancer	8.71e-05	0.00147	CcSEcCtD
Daunorubicin—CYP1A1—skin of body—germ cell cancer	8.68e-05	0.00282	CbGeAlD
Daunorubicin—YWHAG—LKB1 signaling events—MYC—germ cell cancer	8.68e-05	0.00271	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—RARS—germ cell cancer	8.67e-05	0.00271	CbGpPWpGaD
Daunorubicin—Alopecia—Ifosfamide—germ cell cancer	8.66e-05	0.00146	CcSEcCtD
Daunorubicin—Ill-defined disorder—Dactinomycin—germ cell cancer	8.64e-05	0.00146	CcSEcCtD
Daunorubicin—Anaemia—Dactinomycin—germ cell cancer	8.6e-05	0.00145	CcSEcCtD
Daunorubicin—Erythema—Ifosfamide—germ cell cancer	8.53e-05	0.00144	CcSEcCtD
Daunorubicin—Acute coronary syndrome—Etoposide—germ cell cancer	8.5e-05	0.00143	CcSEcCtD
Daunorubicin—Chest pain—Bleomycin—germ cell cancer	8.5e-05	0.00143	CcSEcCtD
Daunorubicin—Myalgia—Bleomycin—germ cell cancer	8.5e-05	0.00143	CcSEcCtD
Daunorubicin—Renal failure—Etoposide—germ cell cancer	8.47e-05	0.00143	CcSEcCtD
Daunorubicin—Myocardial infarction—Etoposide—germ cell cancer	8.45e-05	0.00143	CcSEcCtD
Daunorubicin—Neuropathy peripheral—Etoposide—germ cell cancer	8.45e-05	0.00143	CcSEcCtD
Daunorubicin—ABCC1—adrenal gland—germ cell cancer	8.42e-05	0.00274	CbGeAlD
Daunorubicin—Stomatitis—Etoposide—germ cell cancer	8.4e-05	0.00142	CcSEcCtD
Daunorubicin—Discomfort—Bleomycin—germ cell cancer	8.39e-05	0.00142	CcSEcCtD
Daunorubicin—Malaise—Dactinomycin—germ cell cancer	8.39e-05	0.00142	CcSEcCtD
Daunorubicin—Decreased appetite—Vinblastine—germ cell cancer	8.38e-05	0.00142	CcSEcCtD
Daunorubicin—TOP2A—lymph node—germ cell cancer	8.38e-05	0.00273	CbGeAlD
Daunorubicin—Urine output increased—Methotrexate—germ cell cancer	8.35e-05	0.00141	CcSEcCtD
Daunorubicin—Leukopenia—Dactinomycin—germ cell cancer	8.33e-05	0.00141	CcSEcCtD
Daunorubicin—CYP3A4—Metapathway biotransformation—NAT9—germ cell cancer	8.32e-05	0.0026	CbGpPWpGaD
Daunorubicin—ABCC2—endocrine gland—germ cell cancer	8.29e-05	0.0027	CbGeAlD
Daunorubicin—Pain—Vinblastine—germ cell cancer	8.25e-05	0.00139	CcSEcCtD
Daunorubicin—Constipation—Vinblastine—germ cell cancer	8.25e-05	0.00139	CcSEcCtD
Daunorubicin—Confusional state—Bleomycin—germ cell cancer	8.21e-05	0.00139	CcSEcCtD
Daunorubicin—Anaphylactic shock—Bleomycin—germ cell cancer	8.14e-05	0.00137	CcSEcCtD
Daunorubicin—Oedema—Bleomycin—germ cell cancer	8.14e-05	0.00137	CcSEcCtD
Daunorubicin—Visual impairment—Cisplatin—germ cell cancer	8.14e-05	0.00137	CcSEcCtD
Daunorubicin—CYP1B1—endocrine gland—germ cell cancer	8.11e-05	0.00264	CbGeAlD
Daunorubicin—Infection—Bleomycin—germ cell cancer	8.09e-05	0.00137	CcSEcCtD
Daunorubicin—YWHAG—SIDS Susceptibility Pathways—AVP—germ cell cancer	8.06e-05	0.00252	CbGpPWpGaD
Daunorubicin—CYP1B1—head—germ cell cancer	8.01e-05	0.00261	CbGeAlD
Daunorubicin—Thrombocytopenia—Bleomycin—germ cell cancer	7.97e-05	0.00135	CcSEcCtD
Daunorubicin—Feeling abnormal—Vinblastine—germ cell cancer	7.95e-05	0.00134	CcSEcCtD
Daunorubicin—ABCG2—uterus—germ cell cancer	7.94e-05	0.00258	CbGeAlD
Daunorubicin—Myalgia—Dactinomycin—germ cell cancer	7.92e-05	0.00134	CcSEcCtD
Daunorubicin—Ill-defined disorder—Ifosfamide—germ cell cancer	7.91e-05	0.00134	CcSEcCtD
Daunorubicin—ABCC2—testis—germ cell cancer	7.9e-05	0.00257	CbGeAlD
Daunorubicin—Gastrointestinal pain—Vinblastine—germ cell cancer	7.89e-05	0.00133	CcSEcCtD
Daunorubicin—TOP2A—Gastric Cancer Network 2—MYC—germ cell cancer	7.89e-05	0.00246	CbGpPWpGaD
Daunorubicin—Anaemia—Ifosfamide—germ cell cancer	7.88e-05	0.00133	CcSEcCtD
Daunorubicin—Tinnitus—Cisplatin—germ cell cancer	7.88e-05	0.00133	CcSEcCtD
Daunorubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—germ cell cancer	7.87e-05	0.00246	CbGpPWpGaD
Daunorubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—germ cell cancer	7.86e-05	0.00245	CbGpPWpGaD
Daunorubicin—Lymphadenopathy—Methotrexate—germ cell cancer	7.85e-05	0.00133	CcSEcCtD
Daunorubicin—ABCC1—female gonad—germ cell cancer	7.85e-05	0.00255	CbGeAlD
Daunorubicin—Cardiac disorder—Cisplatin—germ cell cancer	7.84e-05	0.00132	CcSEcCtD
Daunorubicin—Flushing—Cisplatin—germ cell cancer	7.84e-05	0.00132	CcSEcCtD
Daunorubicin—Agitation—Ifosfamide—germ cell cancer	7.84e-05	0.00132	CcSEcCtD
Daunorubicin—Discomfort—Dactinomycin—germ cell cancer	7.83e-05	0.00132	CcSEcCtD
Daunorubicin—ABCG2—pituitary gland—germ cell cancer	7.8e-05	0.00254	CbGeAlD
Daunorubicin—Anorexia—Bleomycin—germ cell cancer	7.76e-05	0.00131	CcSEcCtD
Daunorubicin—Thrombophlebitis—Methotrexate—germ cell cancer	7.74e-05	0.00131	CcSEcCtD
Daunorubicin—CYP1B1—testis—germ cell cancer	7.74e-05	0.00252	CbGeAlD
Daunorubicin—TOP2A—Vincristine—Vinblastine—germ cell cancer	7.72e-05	0.0499	CbGdCrCtD
Daunorubicin—Malaise—Ifosfamide—germ cell cancer	7.69e-05	0.0013	CcSEcCtD
Daunorubicin—Leukopenia—Ifosfamide—germ cell cancer	7.63e-05	0.00129	CcSEcCtD
Daunorubicin—Polyuria—Methotrexate—germ cell cancer	7.63e-05	0.00129	CcSEcCtD
Daunorubicin—Abdominal pain—Vinblastine—germ cell cancer	7.62e-05	0.00129	CcSEcCtD
Daunorubicin—Oedema—Dactinomycin—germ cell cancer	7.6e-05	0.00128	CcSEcCtD
Daunorubicin—Infection—Dactinomycin—germ cell cancer	7.55e-05	0.00127	CcSEcCtD
Daunorubicin—Arrhythmia—Cisplatin—germ cell cancer	7.55e-05	0.00127	CcSEcCtD
Daunorubicin—CYP1A1—uterus—germ cell cancer	7.54e-05	0.00245	CbGeAlD
Daunorubicin—Palpitations—Ifosfamide—germ cell cancer	7.54e-05	0.00127	CcSEcCtD
Daunorubicin—ABCG2—medulla oblongata—germ cell cancer	7.53e-05	0.00245	CbGeAlD
Daunorubicin—Alopecia—Cisplatin—germ cell cancer	7.46e-05	0.00126	CcSEcCtD
Daunorubicin—Cough—Ifosfamide—germ cell cancer	7.44e-05	0.00126	CcSEcCtD
Daunorubicin—Thrombocytopenia—Dactinomycin—germ cell cancer	7.44e-05	0.00126	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Bleomycin—germ cell cancer	7.42e-05	0.00125	CcSEcCtD
Daunorubicin—Convulsion—Ifosfamide—germ cell cancer	7.39e-05	0.00125	CcSEcCtD
Daunorubicin—ABCC10—brain—germ cell cancer	7.38e-05	0.0024	CbGeAlD
Daunorubicin—Hypertension—Ifosfamide—germ cell cancer	7.36e-05	0.00124	CcSEcCtD
Daunorubicin—Erythema—Cisplatin—germ cell cancer	7.35e-05	0.00124	CcSEcCtD
Daunorubicin—Dyspnoea—Bleomycin—germ cell cancer	7.26e-05	0.00123	CcSEcCtD
Daunorubicin—Arthralgia—Ifosfamide—germ cell cancer	7.26e-05	0.00123	CcSEcCtD
Daunorubicin—Chest pain—Ifosfamide—germ cell cancer	7.26e-05	0.00123	CcSEcCtD
Daunorubicin—Myalgia—Ifosfamide—germ cell cancer	7.26e-05	0.00123	CcSEcCtD
Daunorubicin—Anorexia—Dactinomycin—germ cell cancer	7.24e-05	0.00122	CcSEcCtD
Daunorubicin—Cardiac disorder—Etoposide—germ cell cancer	7.18e-05	0.00121	CcSEcCtD
Daunorubicin—Flushing—Etoposide—germ cell cancer	7.18e-05	0.00121	CcSEcCtD
Daunorubicin—Discomfort—Ifosfamide—germ cell cancer	7.17e-05	0.00121	CcSEcCtD
Daunorubicin—CYP1B1—cerebellum—germ cell cancer	7.15e-05	0.00233	CbGeAlD
Daunorubicin—ABCC10—lymph node—germ cell cancer	7.13e-05	0.00232	CbGeAlD
Daunorubicin—YWHAG—LKB1 signaling events—TP53—germ cell cancer	7.13e-05	0.00223	CbGpPWpGaD
Daunorubicin—Hypersensitivity—Vinblastine—germ cell cancer	7.1e-05	0.0012	CcSEcCtD
Daunorubicin—Decreased appetite—Bleomycin—germ cell cancer	7.08e-05	0.0012	CcSEcCtD
Daunorubicin—Confusional state—Ifosfamide—germ cell cancer	7.02e-05	0.00118	CcSEcCtD
Daunorubicin—ABCG2—adrenal gland—germ cell cancer	6.97e-05	0.00227	CbGeAlD
Daunorubicin—Pain—Bleomycin—germ cell cancer	6.96e-05	0.00118	CcSEcCtD
Daunorubicin—Oedema—Ifosfamide—germ cell cancer	6.96e-05	0.00118	CcSEcCtD
Daunorubicin—Anaphylactic shock—Ifosfamide—germ cell cancer	6.96e-05	0.00118	CcSEcCtD
Daunorubicin—ABCC1—testis—germ cell cancer	6.96e-05	0.00226	CbGeAlD
Daunorubicin—Chills—Etoposide—germ cell cancer	6.94e-05	0.00117	CcSEcCtD
Daunorubicin—Anaphylactoid reaction—Methotrexate—germ cell cancer	6.92e-05	0.00117	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	6.92e-05	0.00117	CcSEcCtD
Daunorubicin—Asthenia—Vinblastine—germ cell cancer	6.92e-05	0.00117	CcSEcCtD
Daunorubicin—Infection—Ifosfamide—germ cell cancer	6.92e-05	0.00117	CcSEcCtD
Daunorubicin—Tremor—Cisplatin—germ cell cancer	6.89e-05	0.00116	CcSEcCtD
Daunorubicin—ABCG2—midbrain—germ cell cancer	6.88e-05	0.00224	CbGeAlD
Daunorubicin—Alopecia—Etoposide—germ cell cancer	6.84e-05	0.00115	CcSEcCtD
Daunorubicin—Ill-defined disorder—Cisplatin—germ cell cancer	6.82e-05	0.00115	CcSEcCtD
Daunorubicin—Thrombocytopenia—Ifosfamide—germ cell cancer	6.82e-05	0.00115	CcSEcCtD
Daunorubicin—Anaemia—Cisplatin—germ cell cancer	6.8e-05	0.00115	CcSEcCtD
Daunorubicin—ABCG2—bone marrow—germ cell cancer	6.74e-05	0.00219	CbGeAlD
Daunorubicin—Hyperhidrosis—Ifosfamide—germ cell cancer	6.73e-05	0.00114	CcSEcCtD
Daunorubicin—ABCG2—spinal cord—germ cell cancer	6.71e-05	0.00218	CbGeAlD
Daunorubicin—Feeling abnormal—Bleomycin—germ cell cancer	6.71e-05	0.00113	CcSEcCtD
Daunorubicin—Anorexia—Ifosfamide—germ cell cancer	6.64e-05	0.00112	CcSEcCtD
Daunorubicin—Malaise—Cisplatin—germ cell cancer	6.63e-05	0.00112	CcSEcCtD
Daunorubicin—Decreased appetite—Dactinomycin—germ cell cancer	6.6e-05	0.00111	CcSEcCtD
Daunorubicin—Diarrhoea—Vinblastine—germ cell cancer	6.6e-05	0.00111	CcSEcCtD
Daunorubicin—Dysgeusia—Etoposide—germ cell cancer	6.6e-05	0.00111	CcSEcCtD
Daunorubicin—Leukopenia—Cisplatin—germ cell cancer	6.58e-05	0.00111	CcSEcCtD
Daunorubicin—YWHAG—a6b1 and a6b4 Integrin signaling—HRAS—germ cell cancer	6.57e-05	0.00205	CbGpPWpGaD
Daunorubicin—Fatigue—Dactinomycin—germ cell cancer	6.55e-05	0.00111	CcSEcCtD
Daunorubicin—Back pain—Etoposide—germ cell cancer	6.52e-05	0.0011	CcSEcCtD
Daunorubicin—ABCG2—female gonad—germ cell cancer	6.5e-05	0.00211	CbGeAlD
Daunorubicin—Pain—Dactinomycin—germ cell cancer	6.5e-05	0.0011	CcSEcCtD
Daunorubicin—TOP2A—Gastric Cancer Network 2—TP53—germ cell cancer	6.48e-05	0.00202	CbGpPWpGaD
Daunorubicin—Urticaria—Bleomycin—germ cell cancer	6.47e-05	0.00109	CcSEcCtD
Daunorubicin—Body temperature increased—Bleomycin—germ cell cancer	6.44e-05	0.00109	CcSEcCtD
Daunorubicin—ABCC1—cerebellum—germ cell cancer	6.43e-05	0.00209	CbGeAlD
Daunorubicin—Dizziness—Vinblastine—germ cell cancer	6.38e-05	0.00108	CcSEcCtD
Daunorubicin—Convulsion—Cisplatin—germ cell cancer	6.37e-05	0.00108	CcSEcCtD
Daunorubicin—Mood swings—Methotrexate—germ cell cancer	6.35e-05	0.00107	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	6.34e-05	0.00107	CcSEcCtD
Daunorubicin—Ataxia—Methotrexate—germ cell cancer	6.3e-05	0.00106	CcSEcCtD
Daunorubicin—Myalgia—Cisplatin—germ cell cancer	6.26e-05	0.00106	CcSEcCtD
Daunorubicin—Feeling abnormal—Dactinomycin—germ cell cancer	6.26e-05	0.00106	CcSEcCtD
Daunorubicin—Ill-defined disorder—Etoposide—germ cell cancer	6.25e-05	0.00106	CcSEcCtD
Daunorubicin—Anxiety—Cisplatin—germ cell cancer	6.24e-05	0.00105	CcSEcCtD
Daunorubicin—Anaemia—Etoposide—germ cell cancer	6.23e-05	0.00105	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Dactinomycin—germ cell cancer	6.21e-05	0.00105	CcSEcCtD
Daunorubicin—Dyspnoea—Ifosfamide—germ cell cancer	6.21e-05	0.00105	CcSEcCtD
Daunorubicin—Somnolence—Ifosfamide—germ cell cancer	6.19e-05	0.00104	CcSEcCtD
Daunorubicin—Discomfort—Cisplatin—germ cell cancer	6.18e-05	0.00104	CcSEcCtD
Daunorubicin—CYP1A1—female gonad—germ cell cancer	6.17e-05	0.00201	CbGeAlD
Daunorubicin—Vomiting—Vinblastine—germ cell cancer	6.13e-05	0.00104	CcSEcCtD
Daunorubicin—Malaise—Etoposide—germ cell cancer	6.07e-05	0.00103	CcSEcCtD
Daunorubicin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	6.05e-05	0.00189	CbGpPWpGaD
Daunorubicin—Decreased appetite—Ifosfamide—germ cell cancer	6.05e-05	0.00102	CcSEcCtD
Daunorubicin—Headache—Vinblastine—germ cell cancer	6.04e-05	0.00102	CcSEcCtD
Daunorubicin—CYP3A5—female gonad—germ cell cancer	6.03e-05	0.00196	CbGeAlD
Daunorubicin—Leukopenia—Etoposide—germ cell cancer	6.03e-05	0.00102	CcSEcCtD
Daunorubicin—ABCB1—trigeminal ganglion—germ cell cancer	6.01e-05	0.00196	CbGeAlD
Daunorubicin—Abdominal pain—Dactinomycin—germ cell cancer	6e-05	0.00101	CcSEcCtD
Daunorubicin—Body temperature increased—Dactinomycin—germ cell cancer	6e-05	0.00101	CcSEcCtD
Daunorubicin—Fatigue—Ifosfamide—germ cell cancer	6e-05	0.00101	CcSEcCtD
Daunorubicin—Oedema—Cisplatin—germ cell cancer	6e-05	0.00101	CcSEcCtD
Daunorubicin—Anaphylactic shock—Cisplatin—germ cell cancer	6e-05	0.00101	CcSEcCtD
Daunorubicin—Hypersensitivity—Bleomycin—germ cell cancer	6e-05	0.00101	CcSEcCtD
Daunorubicin—Infection—Cisplatin—germ cell cancer	5.96e-05	0.00101	CcSEcCtD
Daunorubicin—Pain—Ifosfamide—germ cell cancer	5.95e-05	0.001	CcSEcCtD
Daunorubicin—Constipation—Ifosfamide—germ cell cancer	5.95e-05	0.001	CcSEcCtD
Daunorubicin—Loss of consciousness—Etoposide—germ cell cancer	5.92e-05	0.000999	CcSEcCtD
Daunorubicin—Cough—Etoposide—germ cell cancer	5.88e-05	0.000992	CcSEcCtD
Daunorubicin—Thrombocytopenia—Cisplatin—germ cell cancer	5.88e-05	0.000992	CcSEcCtD
Daunorubicin—Tachycardia—Cisplatin—germ cell cancer	5.86e-05	0.000989	CcSEcCtD
Daunorubicin—Asthenia—Bleomycin—germ cell cancer	5.84e-05	0.000986	CcSEcCtD
Daunorubicin—Convulsion—Etoposide—germ cell cancer	5.84e-05	0.000985	CcSEcCtD
Daunorubicin—Hypertension—Etoposide—germ cell cancer	5.82e-05	0.000982	CcSEcCtD
Daunorubicin—CYP1A2—endocrine gland—germ cell cancer	5.82e-05	0.00189	CbGeAlD
Daunorubicin—ABCB1—embryo—germ cell cancer	5.81e-05	0.00189	CbGeAlD
Daunorubicin—CYP1B1—brain—germ cell cancer	5.81e-05	0.00189	CbGeAlD
Daunorubicin—Hyperhidrosis—Cisplatin—germ cell cancer	5.8e-05	0.000979	CcSEcCtD
Daunorubicin—ABCG2—testis—germ cell cancer	5.76e-05	0.00187	CbGeAlD
Daunorubicin—Pruritus—Bleomycin—germ cell cancer	5.76e-05	0.000973	CcSEcCtD
Daunorubicin—CYP1A1—endocrine gland—germ cell cancer	5.74e-05	0.00187	CbGeAlD
Daunorubicin—Feeling abnormal—Ifosfamide—germ cell cancer	5.74e-05	0.000968	CcSEcCtD
Daunorubicin—Chest pain—Etoposide—germ cell cancer	5.73e-05	0.000968	CcSEcCtD
Daunorubicin—Nausea—Vinblastine—germ cell cancer	5.73e-05	0.000967	CcSEcCtD
Daunorubicin—ABCC2—lymph node—germ cell cancer	5.73e-05	0.00186	CbGeAlD
Daunorubicin—Anorexia—Cisplatin—germ cell cancer	5.72e-05	0.000966	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Ifosfamide—germ cell cancer	5.69e-05	0.000961	CcSEcCtD
Daunorubicin—Discomfort—Etoposide—germ cell cancer	5.67e-05	0.000957	CcSEcCtD
Daunorubicin—CYP1A1—head—germ cell cancer	5.66e-05	0.00184	CbGeAlD
Daunorubicin—CYP1B1—lymph node—germ cell cancer	5.61e-05	0.00182	CbGeAlD
Daunorubicin—CYP3A5—endocrine gland—germ cell cancer	5.61e-05	0.00182	CbGeAlD
Daunorubicin—Hypersensitivity—Dactinomycin—germ cell cancer	5.6e-05	0.000945	CcSEcCtD
Daunorubicin—Confusional state—Etoposide—germ cell cancer	5.54e-05	0.000936	CcSEcCtD
Daunorubicin—Urticaria—Ifosfamide—germ cell cancer	5.53e-05	0.000933	CcSEcCtD
Daunorubicin—Abdominal pain—Ifosfamide—germ cell cancer	5.5e-05	0.000929	CcSEcCtD
Daunorubicin—Body temperature increased—Ifosfamide—germ cell cancer	5.5e-05	0.000929	CcSEcCtD
Daunorubicin—Pancytopenia—Methotrexate—germ cell cancer	5.5e-05	0.000928	CcSEcCtD
Daunorubicin—Anaphylactic shock—Etoposide—germ cell cancer	5.5e-05	0.000928	CcSEcCtD
Daunorubicin—Musculoskeletal discomfort—Cisplatin—germ cell cancer	5.47e-05	0.000923	CcSEcCtD
Daunorubicin—Infection—Etoposide—germ cell cancer	5.46e-05	0.000922	CcSEcCtD
Daunorubicin—Asthenia—Dactinomycin—germ cell cancer	5.45e-05	0.00092	CcSEcCtD
Daunorubicin—Neutropenia—Methotrexate—germ cell cancer	5.41e-05	0.000914	CcSEcCtD
Daunorubicin—Dysuria—Methotrexate—germ cell cancer	5.41e-05	0.000914	CcSEcCtD
Daunorubicin—Thrombocytopenia—Etoposide—germ cell cancer	5.38e-05	0.000909	CcSEcCtD
Daunorubicin—Tachycardia—Etoposide—germ cell cancer	5.37e-05	0.000906	CcSEcCtD
Daunorubicin—Dyspnoea—Cisplatin—germ cell cancer	5.35e-05	0.000903	CcSEcCtD
Daunorubicin—ABCG2—cerebellum—germ cell cancer	5.32e-05	0.00173	CbGeAlD
Daunorubicin—Hyperhidrosis—Etoposide—germ cell cancer	5.31e-05	0.000897	CcSEcCtD
Daunorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—germ cell cancer	5.28e-05	0.00165	CbGpPWpGaD
Daunorubicin—Anorexia—Etoposide—germ cell cancer	5.24e-05	0.000885	CcSEcCtD
Daunorubicin—ABCC1—brain—germ cell cancer	5.22e-05	0.0017	CbGeAlD
Daunorubicin—Decreased appetite—Cisplatin—germ cell cancer	5.22e-05	0.000881	CcSEcCtD
Daunorubicin—Diarrhoea—Dactinomycin—germ cell cancer	5.2e-05	0.000877	CcSEcCtD
Daunorubicin—Vomiting—Bleomycin—germ cell cancer	5.18e-05	0.000874	CcSEcCtD
Daunorubicin—Depression—Methotrexate—germ cell cancer	5.15e-05	0.000869	CcSEcCtD
Daunorubicin—Rash—Bleomycin—germ cell cancer	5.14e-05	0.000867	CcSEcCtD
Daunorubicin—ABCB1—retina—germ cell cancer	5.14e-05	0.00167	CbGeAlD
Daunorubicin—Pain—Cisplatin—germ cell cancer	5.13e-05	0.000866	CcSEcCtD
Daunorubicin—Dermatitis—Bleomycin—germ cell cancer	5.13e-05	0.000866	CcSEcCtD
Daunorubicin—Hypersensitivity—Ifosfamide—germ cell cancer	5.13e-05	0.000866	CcSEcCtD
Daunorubicin—Renal failure—Methotrexate—germ cell cancer	5.08e-05	0.000857	CcSEcCtD
Daunorubicin—ABCC1—lymph node—germ cell cancer	5.05e-05	0.00164	CbGeAlD
Daunorubicin—Stomatitis—Methotrexate—germ cell cancer	5.03e-05	0.00085	CcSEcCtD
Daunorubicin—Conjunctivitis—Methotrexate—germ cell cancer	5.02e-05	0.000847	CcSEcCtD
Daunorubicin—Asthenia—Ifosfamide—germ cell cancer	4.99e-05	0.000843	CcSEcCtD
Daunorubicin—ABCC6—Transmembrane transport of small molecules—AVP—germ cell cancer	4.97e-05	0.00155	CbGpPWpGaD
Daunorubicin—Feeling abnormal—Cisplatin—germ cell cancer	4.95e-05	0.000835	CcSEcCtD
Daunorubicin—Pruritus—Ifosfamide—germ cell cancer	4.92e-05	0.000831	CcSEcCtD
Daunorubicin—Dyspnoea—Etoposide—germ cell cancer	4.9e-05	0.000827	CcSEcCtD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	4.89e-05	0.00153	CbGpPWpGaD
Daunorubicin—Somnolence—Etoposide—germ cell cancer	4.89e-05	0.000825	CcSEcCtD
Daunorubicin—Nausea—Bleomycin—germ cell cancer	4.84e-05	0.000817	CcSEcCtD
Daunorubicin—YWHAG—mTOR signaling pathway—HRAS—germ cell cancer	4.84e-05	0.00151	CbGpPWpGaD
Daunorubicin—Vomiting—Dactinomycin—germ cell cancer	4.83e-05	0.000815	CcSEcCtD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	4.82e-05	0.00151	CbGpPWpGaD
Daunorubicin—Rash—Dactinomycin—germ cell cancer	4.79e-05	0.000809	CcSEcCtD
Daunorubicin—Decreased appetite—Etoposide—germ cell cancer	4.78e-05	0.000807	CcSEcCtD
Daunorubicin—Diarrhoea—Ifosfamide—germ cell cancer	4.76e-05	0.000804	CcSEcCtD
Daunorubicin—Body temperature increased—Cisplatin—germ cell cancer	4.74e-05	0.000801	CcSEcCtD
Daunorubicin—Fatigue—Etoposide—germ cell cancer	4.74e-05	0.0008	CcSEcCtD
Daunorubicin—ABCB1—telencephalon—germ cell cancer	4.72e-05	0.00154	CbGeAlD
Daunorubicin—Constipation—Etoposide—germ cell cancer	4.7e-05	0.000794	CcSEcCtD
Daunorubicin—Pain—Etoposide—germ cell cancer	4.7e-05	0.000794	CcSEcCtD
Daunorubicin—Dizziness—Ifosfamide—germ cell cancer	4.6e-05	0.000777	CcSEcCtD
Daunorubicin—TOP2A—Circadian rythm related genes—AVP—germ cell cancer	4.6e-05	0.00144	CbGpPWpGaD
Daunorubicin—Feeling abnormal—Etoposide—germ cell cancer	4.53e-05	0.000765	CcSEcCtD
Daunorubicin—Nausea—Dactinomycin—germ cell cancer	4.51e-05	0.000762	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Etoposide—germ cell cancer	4.5e-05	0.000759	CcSEcCtD
Daunorubicin—ABCB1—decidua—germ cell cancer	4.48e-05	0.00146	CbGeAlD
Daunorubicin—Visual impairment—Methotrexate—germ cell cancer	4.47e-05	0.000754	CcSEcCtD
Daunorubicin—Vomiting—Ifosfamide—germ cell cancer	4.43e-05	0.000747	CcSEcCtD
Daunorubicin—Hypersensitivity—Cisplatin—germ cell cancer	4.42e-05	0.000746	CcSEcCtD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	4.42e-05	0.00138	CbGpPWpGaD
Daunorubicin—Rash—Ifosfamide—germ cell cancer	4.39e-05	0.000741	CcSEcCtD
Daunorubicin—Dermatitis—Ifosfamide—germ cell cancer	4.38e-05	0.00074	CcSEcCtD
Daunorubicin—Urticaria—Etoposide—germ cell cancer	4.37e-05	0.000737	CcSEcCtD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	4.37e-05	0.00136	CbGpPWpGaD
Daunorubicin—Body temperature increased—Etoposide—germ cell cancer	4.35e-05	0.000734	CcSEcCtD
Daunorubicin—Abdominal pain—Etoposide—germ cell cancer	4.35e-05	0.000734	CcSEcCtD
Daunorubicin—ABCC10—Transmembrane transport of small molecules—AVP—germ cell cancer	4.34e-05	0.00136	CbGpPWpGaD
Daunorubicin—ABCG2—brain—germ cell cancer	4.32e-05	0.00141	CbGeAlD
Daunorubicin—Tinnitus—Methotrexate—germ cell cancer	4.32e-05	0.00073	CcSEcCtD
Daunorubicin—Asthenia—Cisplatin—germ cell cancer	4.31e-05	0.000727	CcSEcCtD
Daunorubicin—Cardiac disorder—Methotrexate—germ cell cancer	4.3e-05	0.000726	CcSEcCtD
Daunorubicin—CYP3A4—endocrine gland—germ cell cancer	4.21e-05	0.00137	CbGeAlD
Daunorubicin—ABCG2—lymph node—germ cell cancer	4.18e-05	0.00136	CbGeAlD
Daunorubicin—Chills—Methotrexate—germ cell cancer	4.16e-05	0.000702	CcSEcCtD
Daunorubicin—Nausea—Ifosfamide—germ cell cancer	4.13e-05	0.000698	CcSEcCtD
Daunorubicin—Diarrhoea—Cisplatin—germ cell cancer	4.11e-05	0.000693	CcSEcCtD
Daunorubicin—CYP1A1—brain—germ cell cancer	4.1e-05	0.00134	CbGeAlD
Daunorubicin—Alopecia—Methotrexate—germ cell cancer	4.1e-05	0.000691	CcSEcCtD
Daunorubicin—Hypersensitivity—Etoposide—germ cell cancer	4.05e-05	0.000684	CcSEcCtD
Daunorubicin—Erythema—Methotrexate—germ cell cancer	4.03e-05	0.000681	CcSEcCtD
Daunorubicin—CYP1A1—lymph node—germ cell cancer	3.97e-05	0.00129	CbGeAlD
Daunorubicin—Dysgeusia—Methotrexate—germ cell cancer	3.95e-05	0.000667	CcSEcCtD
Daunorubicin—Asthenia—Etoposide—germ cell cancer	3.94e-05	0.000666	CcSEcCtD
Daunorubicin—ABCB1—gonad—germ cell cancer	3.94e-05	0.00128	CbGeAlD
Daunorubicin—ABCB1—uterus—germ cell cancer	3.92e-05	0.00127	CbGeAlD
Daunorubicin—Back pain—Methotrexate—germ cell cancer	3.9e-05	0.000659	CcSEcCtD
Daunorubicin—Pruritus—Etoposide—germ cell cancer	3.89e-05	0.000657	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	3.85e-05	0.0012	CbGpPWpGaD
Daunorubicin—ABCB1—pituitary gland—germ cell cancer	3.85e-05	0.00125	CbGeAlD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	3.84e-05	0.0012	CbGpPWpGaD
Daunorubicin—Vomiting—Cisplatin—germ cell cancer	3.82e-05	0.000644	CcSEcCtD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	3.8e-05	0.00119	CbGpPWpGaD
Daunorubicin—Rash—Cisplatin—germ cell cancer	3.78e-05	0.000639	CcSEcCtD
Daunorubicin—Dermatitis—Cisplatin—germ cell cancer	3.78e-05	0.000638	CcSEcCtD
Daunorubicin—Diarrhoea—Etoposide—germ cell cancer	3.76e-05	0.000635	CcSEcCtD
Daunorubicin—ABCG2—Fluoropyrimidine Activity—TP53—germ cell cancer	3.75e-05	0.00117	CbGpPWpGaD
Daunorubicin—Ill-defined disorder—Methotrexate—germ cell cancer	3.74e-05	0.000632	CcSEcCtD
Daunorubicin—Anaemia—Methotrexate—germ cell cancer	3.73e-05	0.00063	CcSEcCtD
Daunorubicin—ABCB1—medulla oblongata—germ cell cancer	3.71e-05	0.00121	CbGeAlD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—MYC—germ cell cancer	3.7e-05	0.00115	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	3.69e-05	0.00115	CbGpPWpGaD
Daunorubicin—Malaise—Methotrexate—germ cell cancer	3.64e-05	0.000614	CcSEcCtD
Daunorubicin—Dizziness—Etoposide—germ cell cancer	3.64e-05	0.000614	CcSEcCtD
Daunorubicin—Leukopenia—Methotrexate—germ cell cancer	3.61e-05	0.00061	CcSEcCtD
Daunorubicin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—germ cell cancer	3.61e-05	0.00113	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—germ cell cancer	3.57e-05	0.00112	CbGpPWpGaD
Daunorubicin—Nausea—Cisplatin—germ cell cancer	3.56e-05	0.000602	CcSEcCtD
Daunorubicin—Cough—Methotrexate—germ cell cancer	3.52e-05	0.000594	CcSEcCtD
Daunorubicin—Convulsion—Methotrexate—germ cell cancer	3.5e-05	0.00059	CcSEcCtD
Daunorubicin—Vomiting—Etoposide—germ cell cancer	3.5e-05	0.00059	CcSEcCtD
Daunorubicin—Rash—Etoposide—germ cell cancer	3.47e-05	0.000585	CcSEcCtD
Daunorubicin—Dermatitis—Etoposide—germ cell cancer	3.46e-05	0.000585	CcSEcCtD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	3.45e-05	0.00108	CbGpPWpGaD
Daunorubicin—Headache—Etoposide—germ cell cancer	3.44e-05	0.000581	CcSEcCtD
Daunorubicin—ABCB1—adrenal gland—germ cell cancer	3.44e-05	0.00112	CbGeAlD
Daunorubicin—Chest pain—Methotrexate—germ cell cancer	3.44e-05	0.00058	CcSEcCtD
Daunorubicin—Myalgia—Methotrexate—germ cell cancer	3.44e-05	0.00058	CcSEcCtD
Daunorubicin—Arthralgia—Methotrexate—germ cell cancer	3.44e-05	0.00058	CcSEcCtD
Daunorubicin—Discomfort—Methotrexate—germ cell cancer	3.39e-05	0.000573	CcSEcCtD
Daunorubicin—ABCB1—midbrain—germ cell cancer	3.39e-05	0.0011	CbGeAlD
Daunorubicin—YWHAG—ErbB1 downstream signaling—HRAS—germ cell cancer	3.34e-05	0.00104	CbGpPWpGaD
Daunorubicin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	3.33e-05	0.00104	CbGpPWpGaD
Daunorubicin—ABCB1—bone marrow—germ cell cancer	3.32e-05	0.00108	CbGeAlD
Daunorubicin—Confusional state—Methotrexate—germ cell cancer	3.32e-05	0.000561	CcSEcCtD
Daunorubicin—ABCB1—spinal cord—germ cell cancer	3.31e-05	0.00108	CbGeAlD
Daunorubicin—YWHAG—Cell Cycle—H2AFZ—germ cell cancer	3.3e-05	0.00103	CbGpPWpGaD
Daunorubicin—Anaphylactic shock—Methotrexate—germ cell cancer	3.29e-05	0.000556	CcSEcCtD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—germ cell cancer	3.27e-05	0.00102	CbGpPWpGaD
Daunorubicin—Infection—Methotrexate—germ cell cancer	3.27e-05	0.000552	CcSEcCtD
Daunorubicin—Nausea—Etoposide—germ cell cancer	3.27e-05	0.000551	CcSEcCtD
Daunorubicin—NR5A1—Gene Expression—H2AFZ—germ cell cancer	3.26e-05	0.00102	CbGpPWpGaD
Daunorubicin—Thrombocytopenia—Methotrexate—germ cell cancer	3.22e-05	0.000544	CcSEcCtD
Daunorubicin—ABCB11—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	3.21e-05	0.001	CbGpPWpGaD
Daunorubicin—ABCB1—female gonad—germ cell cancer	3.2e-05	0.00104	CbGeAlD
Daunorubicin—Hyperhidrosis—Methotrexate—germ cell cancer	3.18e-05	0.000537	CcSEcCtD
Daunorubicin—Anorexia—Methotrexate—germ cell cancer	3.14e-05	0.00053	CcSEcCtD
Daunorubicin—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	3.02e-05	0.000944	CbGpPWpGaD
Daunorubicin—Musculoskeletal discomfort—Methotrexate—germ cell cancer	3e-05	0.000506	CcSEcCtD
Daunorubicin—ABCB1—endocrine gland—germ cell cancer	2.98e-05	0.000969	CbGeAlD
Daunorubicin—Insomnia—Methotrexate—germ cell cancer	2.98e-05	0.000503	CcSEcCtD
Daunorubicin—ABCB1—head—germ cell cancer	2.94e-05	0.000957	CbGeAlD
Daunorubicin—Dyspnoea—Methotrexate—germ cell cancer	2.94e-05	0.000496	CcSEcCtD
Daunorubicin—Somnolence—Methotrexate—germ cell cancer	2.93e-05	0.000494	CcSEcCtD
Daunorubicin—YWHAG—PDGFR-beta signaling pathway—HRAS—germ cell cancer	2.9e-05	0.000907	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.89e-05	0.000903	CbGpPWpGaD
Daunorubicin—Decreased appetite—Methotrexate—germ cell cancer	2.86e-05	0.000483	CcSEcCtD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.86e-05	0.000892	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.85e-05	0.000889	CbGpPWpGaD
Daunorubicin—ABCB1—testis—germ cell cancer	2.84e-05	0.000924	CbGeAlD
Daunorubicin—Fatigue—Methotrexate—germ cell cancer	2.84e-05	0.000479	CcSEcCtD
Daunorubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	2.84e-05	0.000886	CbGpPWpGaD
Daunorubicin—Pain—Methotrexate—germ cell cancer	2.82e-05	0.000475	CcSEcCtD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.81e-05	0.000879	CbGpPWpGaD
Daunorubicin—Feeling abnormal—Methotrexate—germ cell cancer	2.71e-05	0.000458	CcSEcCtD
Daunorubicin—Gastrointestinal pain—Methotrexate—germ cell cancer	2.69e-05	0.000455	CcSEcCtD
Daunorubicin—ABCB1—cerebellum—germ cell cancer	2.62e-05	0.000854	CbGeAlD
Daunorubicin—Urticaria—Methotrexate—germ cell cancer	2.62e-05	0.000442	CcSEcCtD
Daunorubicin—Abdominal pain—Methotrexate—germ cell cancer	2.6e-05	0.000439	CcSEcCtD
Daunorubicin—Body temperature increased—Methotrexate—germ cell cancer	2.6e-05	0.000439	CcSEcCtD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	2.58e-05	0.000806	CbGpPWpGaD
Daunorubicin—YWHAG—Apoptosis—TP53—germ cell cancer	2.56e-05	0.000798	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.51e-05	0.000785	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	2.49e-05	0.000777	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.48e-05	0.000773	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	2.45e-05	0.000765	CbGpPWpGaD
Daunorubicin—TOP2A—Mitotic G1-G1/S phases—MYC—germ cell cancer	2.43e-05	0.000759	CbGpPWpGaD
Daunorubicin—Hypersensitivity—Methotrexate—germ cell cancer	2.43e-05	0.00041	CcSEcCtD
Daunorubicin—XDH—Metabolism—SLC2A3—germ cell cancer	2.42e-05	0.000754	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.41e-05	0.000753	CbGpPWpGaD
Daunorubicin—XDH—Metabolism—SLC22A3—germ cell cancer	2.38e-05	0.000743	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	2.37e-05	0.000741	CbGpPWpGaD
Daunorubicin—Asthenia—Methotrexate—germ cell cancer	2.36e-05	0.000399	CcSEcCtD
Daunorubicin—NR5A1—Generic Transcription Pathway—MYC—germ cell cancer	2.34e-05	0.000731	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	2.33e-05	0.000729	CbGpPWpGaD
Daunorubicin—Pruritus—Methotrexate—germ cell cancer	2.33e-05	0.000393	CcSEcCtD
Daunorubicin—TOP2A—Cell Cycle—H2AFZ—germ cell cancer	2.31e-05	0.000721	CbGpPWpGaD
Daunorubicin—SLC22A2—SLC-mediated transmembrane transport—AVP—germ cell cancer	2.26e-05	0.000705	CbGpPWpGaD
Daunorubicin—Diarrhoea—Methotrexate—germ cell cancer	2.25e-05	0.00038	CcSEcCtD
Daunorubicin—Dizziness—Methotrexate—germ cell cancer	2.18e-05	0.000368	CcSEcCtD
Daunorubicin—ABCB1—brain—germ cell cancer	2.13e-05	0.000693	CbGeAlD
Daunorubicin—Vomiting—Methotrexate—germ cell cancer	2.09e-05	0.000353	CcSEcCtD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	2.08e-05	0.000649	CbGpPWpGaD
Daunorubicin—Rash—Methotrexate—germ cell cancer	2.08e-05	0.000351	CcSEcCtD
Daunorubicin—Dermatitis—Methotrexate—germ cell cancer	2.07e-05	0.00035	CcSEcCtD
Daunorubicin—Headache—Methotrexate—germ cell cancer	2.06e-05	0.000348	CcSEcCtD
Daunorubicin—ABCB1—lymph node—germ cell cancer	2.06e-05	0.00067	CbGeAlD
Daunorubicin—Nausea—Methotrexate—germ cell cancer	1.96e-05	0.00033	CcSEcCtD
Daunorubicin—XDH—Metabolism—CRABP1—germ cell cancer	1.94e-05	0.000606	CbGpPWpGaD
Daunorubicin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	1.86e-05	0.000582	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	1.84e-05	0.000575	CbGpPWpGaD
Daunorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—germ cell cancer	1.8e-05	0.000562	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—SLC2A3—germ cell cancer	1.78e-05	0.000556	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—SLC22A3—germ cell cancer	1.75e-05	0.000548	CbGpPWpGaD
Daunorubicin—NR5A1—Developmental Biology—HRAS—germ cell cancer	1.73e-05	0.00054	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—SLC2A3—germ cell cancer	1.6e-05	0.000499	CbGpPWpGaD
Daunorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	1.51e-05	0.000472	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	1.51e-05	0.000472	CbGpPWpGaD
Daunorubicin—TOP2A—Circadian rythm related genes—TP53—germ cell cancer	1.45e-05	0.000453	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	1.44e-05	0.000449	CbGpPWpGaD
Daunorubicin—ABCB11—Metabolism—CRABP1—germ cell cancer	1.43e-05	0.000447	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.36e-05	0.000424	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.34e-05	0.000418	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—SLC2A3—germ cell cancer	1.34e-05	0.000418	CbGpPWpGaD
Daunorubicin—ABCC2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.33e-05	0.000416	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—SLC22A3—germ cell cancer	1.32e-05	0.000412	CbGpPWpGaD
Daunorubicin—ABCC1—Transmembrane transport of small molecules—AVP—germ cell cancer	1.32e-05	0.000411	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—SLC2A3—germ cell cancer	1.29e-05	0.000404	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—SLC22A3—germ cell cancer	1.27e-05	0.000398	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle, Mitotic—MYC—germ cell cancer	1.27e-05	0.000398	CbGpPWpGaD
Daunorubicin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	1.19e-05	0.000371	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SLC2A3—germ cell cancer	1.18e-05	0.000368	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SLC2A3—germ cell cancer	1.16e-05	0.000364	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—SLC22A3—germ cell cancer	1.16e-05	0.000362	CbGpPWpGaD
Daunorubicin—ABCG2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.16e-05	0.000362	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—SLC22A3—germ cell cancer	1.15e-05	0.000358	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmembrane transport of small molecules—AVP—germ cell cancer	1.15e-05	0.000358	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—MYC—germ cell cancer	1.14e-05	0.000356	CbGpPWpGaD
Daunorubicin—NR5A1—Gene Expression—MYC—germ cell cancer	1.13e-05	0.000352	CbGpPWpGaD
Daunorubicin—ABCC1—Metabolism—CRABP1—germ cell cancer	1.07e-05	0.000335	CbGpPWpGaD
Daunorubicin—CYP1B1—Metabolism—CRABP1—germ cell cancer	1.04e-05	0.000324	CbGpPWpGaD
Daunorubicin—ABCG2—Metabolism—CRABP1—germ cell cancer	9.45e-06	0.000295	CbGpPWpGaD
Daunorubicin—YWHAG—Cell Cycle—TP53—germ cell cancer	9.36e-06	0.000292	CbGpPWpGaD
Daunorubicin—SLC22A2—Metabolism—CRABP1—germ cell cancer	9.35e-06	0.000292	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—FGF4—germ cell cancer	9.17e-06	0.000287	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	9.16e-06	0.000286	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle, Mitotic—MYC—germ cell cancer	8.91e-06	0.000278	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SLC2A3—germ cell cancer	8.43e-06	0.000263	CbGpPWpGaD
Daunorubicin—SLC22A2—Transmission across Chemical Synapses—HRAS—germ cell cancer	8.4e-06	0.000262	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—SLC22A3—germ cell cancer	8.31e-06	0.000259	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—H2AFZ—germ cell cancer	8.19e-06	0.000256	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—MYC—germ cell cancer	7.97e-06	0.000249	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SLC2A3—germ cell cancer	7.97e-06	0.000249	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—SLC22A3—germ cell cancer	7.85e-06	0.000245	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KITLG—germ cell cancer	7.54e-06	0.000235	CbGpPWpGaD
Daunorubicin—CYP3A5—Metabolism—CRABP1—germ cell cancer	6.77e-06	0.000212	CbGpPWpGaD
Daunorubicin—TOP2A—Cell Cycle—TP53—germ cell cancer	6.55e-06	0.000204	CbGpPWpGaD
Daunorubicin—SLC22A2—Neuronal System—HRAS—germ cell cancer	6.44e-06	0.000201	CbGpPWpGaD
Daunorubicin—CYP1A1—Metabolism—CRABP1—germ cell cancer	6.4e-06	0.0002	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC2A3—germ cell cancer	6.36e-06	0.000199	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—SLC22A3—germ cell cancer	6.27e-06	0.000196	CbGpPWpGaD
Daunorubicin—ABCB1—Transmembrane transport of small molecules—AVP—germ cell cancer	6.27e-06	0.000196	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	6.06e-06	0.000189	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—FGFR3—germ cell cancer	5.6e-06	0.000175	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—KIT—germ cell cancer	5.14e-06	0.000161	CbGpPWpGaD
Daunorubicin—ABCB1—Metabolism—CRABP1—germ cell cancer	5.11e-06	0.00016	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC2A3—germ cell cancer	5.08e-06	0.000159	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—SLC22A3—germ cell cancer	5e-06	0.000156	CbGpPWpGaD
Daunorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	4.98e-06	0.000156	CbGpPWpGaD
Daunorubicin—CYP1A2—Metabolism—CRABP1—germ cell cancer	4.08e-06	0.000127	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC2A3—germ cell cancer	3.92e-06	0.000122	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—SLC22A3—germ cell cancer	3.86e-06	0.000121	CbGpPWpGaD
Daunorubicin—CYP3A4—Metabolism—CRABP1—germ cell cancer	3.15e-06	9.83e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—MYC—germ cell cancer	2.83e-06	8.84e-05	CbGpPWpGaD
Daunorubicin—ABCC1—Disease—HRAS—germ cell cancer	2.22e-06	6.94e-05	CbGpPWpGaD
